CLORAZEPATE DIPOTASSIUM Drug Patent Profile
✉ Email this page to a colleague
When do Clorazepate Dipotassium patents expire, and when can generic versions of Clorazepate Dipotassium launch?
Clorazepate Dipotassium is a drug marketed by Able, Am Therap, Dash Pharms, Dava Pharms Inc, Gd Searle Llc, Purepac Pharm, Quantum Pharmics, Rising, Usl Pharma, Warner Chilcott, Watson Labs, Aurobindo Pharma, Aurolife Pharma Llc, Corepharma, Lederle, Novitium Pharma, Sun Pharm Inds Ltd, and Taro. and is included in fifty-eight NDAs.
The generic ingredient in CLORAZEPATE DIPOTASSIUM is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clorazepate Dipotassium
A generic version of CLORAZEPATE DIPOTASSIUM was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLORAZEPATE DIPOTASSIUM?
- What are the global sales for CLORAZEPATE DIPOTASSIUM?
- What is Average Wholesale Price for CLORAZEPATE DIPOTASSIUM?
Summary for CLORAZEPATE DIPOTASSIUM
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 58 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| Clinical Trials: | 2 |
| Patent Applications: | 339 |
| Drug Prices: | Drug price information for CLORAZEPATE DIPOTASSIUM |
| DailyMed Link: | CLORAZEPATE DIPOTASSIUM at DailyMed |
Recent Clinical Trials for CLORAZEPATE DIPOTASSIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Ranbaxy Laboratories Limited | N/A |
Pharmacology for CLORAZEPATE DIPOTASSIUM
| Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for CLORAZEPATE DIPOTASSIUM
US Patents and Regulatory Information for CLORAZEPATE DIPOTASSIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 071854-001 | Feb 9, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 071858-003 | Jul 17, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | CAPSULE;ORAL | 071879-001 | Mar 15, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lederle | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 072013-001 | Dec 15, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Quantum Pharmics | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 071702-001 | Oct 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
